Please login to the form below
New Accounts, May, 2009, Advertising
New pharmaceutical account wins notified to us by the winning agency for the period March 2009 and April 2009 inclusive:
New pharmaceutical account wins notified to us by the winning agency for the period March 2009 and April 2009 inclusive:
| CLIENT | PRODUCT | THERAPEUTIC AREA | WINNING AGENCY |
| ApaTech | Actifuse | Bone graft material | Fleishman-Hillard International |
| Bausch & Lomb | Ocuvite | Ophthalmology | Pulsar Healthcare Communications |
| Bausch & Lomb | PreserVision | Ophthalmology | Pulsar Healthcare Communications |
| Bupa Home Healthcare | N/A | Corporate | Pulsar Healthcare Communications |
| CarieScan | CarieScan | Dentistry | Pulsar Healthcare Communications |
| IS Pharma | Haemopressin/ Variquel (Europe) | Hepatology | Pulsar Healthcare Communications |
| NHS | PCT strategy | World class commissioning | Hive |
| Pfizer Europe | Celebrex | Arthritis | MSA Market Media |
| Pfizer Europe | Aricept | Alzheimer's disease | MSA Market Media |
| Reckitt Benckiser | Nurofen for Children | Analgesia | Hive |
| Roche | Bonviva | Osteoporosis | MSA Market Media |
| Spectrum Thea | Virgan | Ophthalmology | Pulsar Healthcare Communications |
| Teva Ireland | Naramerg | CNS | Pulsar Healthcare Communications |
| TEVA | Spotlight Range | Various therapy areas | MSA Market Media |
| TEVA | QVAR | Respiratory | MSA Market Media |
Please note that inclusion in this table does not necessarily indicate exclusivity and other agencies may not be involved with some of the products listed in other ways, or in domestic, overseas or international markets.
To submit an entry for New Accounts, email new_accounts@pmlive.com
Share
Related Hub content
Subscribe to our email news alerts
- Planting the Seeds for Future Women Leaders in Medicine
- FDA approves SpringWork’s Ogsiveo as first therapy for desmoid tumours
- GSK shares positive phase 3 results for Blenrep combination in multiple myeloma
- Stem cell therapy trial shows promising results for treating progressive MS
- Cancer Research UK calls on government to create ten-year cancer plan
- Risk calculator to prevent heart attacks and strokes in type 2 diabetes patients
No results were found
PMHub
IPG Health Medical Communications
We are the world's most celebrated and awarded Medical Communications agencies. We are 800 experts obsessed with combining science, creativity...
Latest intelligence
- Millennials: the wellness generation
- Looking at the results from a global healthcare research study focusing on the patients of the future...
- The problem with clinical trials (and how virtual insight-gathering can help)
- While still the gold standard of research, clinical trials are often riddled with issues that limit their applicability to broader populations or delay market access....
- The rise of digital healthcare – fuelled by open innovation in healthtech hubs
- How the ever-increasing uptake of digital solutions is enhancing patient engagement, increasing access to care and lowering the cost of drug development...
